跳至主要内容
临床试验/NCT03495492
NCT03495492Unknown不适用

Dermal Chelation Lowers White Blood Cell Count in Chronic Lymphocytic Leukemia

Optimum Health, Natural Healthcare Center0 个研究点目标入组 50 人开始时间: 2018年12月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
50
主要终点
Serial Total White Blood Cell Count

研究概览

简要总结

The purpose of this clinical trial is to identify 50 participants with Chronic Lymphocytic Leukemia (CLL) and follow their total white blood cell (WBC) counts and absolute lymphocyte counts after performing dermal chelation and administering nutritional therapy

详细描述

The purpose of this clinical trial is to use dermal chelation and hair tissue analysis to identify 50 participants with CLL. The total wbc counts and absolute lymphocyte counts of these participants will be followed after serial dermal chelations and nutritional therapy.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Clinical diagnosis of Chronic Lymphocytic Leukemia and has a toxic heavy metal load
  • Toxic heavy metal load

排除标准

  • Pacemaker implants
  • Organ transplant recipients
  • Psychotic episodes or epileptic seizures

结局指标

主要结局

Serial Total White Blood Cell Count

时间窗: up to 12 months

Total WBC counts taken on a regular interval.

次要结局

未报告次要终点

研究者

发起方
Optimum Health, Natural Healthcare Center
申办方类型
Other
责任方
Sponsor

相似试验